Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan

Trial Identifier: D1690R00022
Sponsor: AstraZeneca
NCTID:: NCT03084965
Start Date: May 2017
Primary Completion Date: March 2018
Study Completion Date: March 2018
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Taiwan Changhua, Taiwan
Taiwan Chiayi, Taiwan
Taiwan Kaohsiung, Taiwan
Taiwan New Taipei, Taiwan
Taiwan Taichung, Taiwan
Taiwan Tainan, Taiwan
Taiwan Taipei, Taiwan
Taiwan Taoyuan, Taiwan